Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
failed trials
Biotech
Kronos shelves sole clinical drug over neurological side effects
The clock is ticking for Kronos Bio after the biotech discontinued its last remaining clinical-stage asset over neurological adverse events.
James Waldron
Nov 14, 2024 5:14am
Syros flunks phase 3 blood cancer trial, triggering loan default
Nov 13, 2024 10:00am
AbbVie's $9B schizophrenia prospect flunks phase 2 trials
Nov 11, 2024 10:06am
Rapt's share price sinks after shelving AD drug under FDA hold
Nov 11, 2024 9:44am
Novo Nordisk discards $1.3B kidney drug in wake of phase 3 fail
Nov 6, 2024 4:54am
Essa drops lead cancer drug after falling short against Xtandi
Nov 1, 2024 7:33am
